Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study KW Garey, M Rege, MP Pai, DE Mingo, KJ Suda, RS Turpin, DT Bearden Clinical infectious diseases 43 (1), 25-31, 2006 | 1436 | 2006 |
Antimicrobial dosing considerations in obese adult patients: insights from the Society of Infectious Diseases Pharmacists MP Pai, DT Bearden Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (8 …, 2007 | 327 | 2007 |
Mechanism of action of and resistance to quinolones DT Bearden, LH Danziger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (10P2 …, 2001 | 156 | 2001 |
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics DT Bearden, KA Rodvold Clinical pharmacokinetics 38, 415-426, 2000 | 149 | 2000 |
A nationwide analysis of antibiotic use in hospice care in the final week of life JS Albrecht, JC McGregor, EK Fromme, DT Bearden, JP Furuno Journal of pain and symptom management 46 (4), 483-490, 2013 | 126 | 2013 |
Quinupristin‐dalfopristin: an overview G Delgado Jr, MM Neuhauser, DT Bearden, LH Danziger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (12 …, 2000 | 96 | 2000 |
Antibiotic prescribing without documented indication in ambulatory care clinics: national cross sectional study MJ Ray, GB Tallman, DT Bearden, MR Elman, JC McGregor Bmj 367, 2019 | 78 | 2019 |
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients JC McGregor, MR Elman, DT Bearden, DH Smith BMC family practice 14, 1-5, 2013 | 76 | 2013 |
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines KW Garey, MP Pai, KJ Suda, RS Turpin, MD Rege, DE Mingo, ... pharmacoepidemiology and drug safety 16 (8), 919-927, 2007 | 75 | 2007 |
Extended‐Spectrum β‐Lactamases: Frequency, Risk Factors, and Outcomes AE Einhorn, MM Neuhauser, DT Bearden, JP Quinn, SL Pendland Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22 (1 …, 2002 | 74 | 2002 |
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis JC McGregor, GP Allen, DT Bearden Therapeutics and clinical risk management 4 (5), 843-853, 2008 | 68 | 2008 |
The essential role of pharmacists in antimicrobial stewardship EL Heil, JL Kuti, DT Bearden, JC Gallagher infection control & hospital epidemiology 37 (7), 753-754, 2016 | 63 | 2016 |
Telithromycin: an oral ketolide for respiratory infections DT Bearden, MM Neuhauser, KW Garey Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (10 …, 2001 | 58 | 2001 |
Frequency of outpatient antibiotic prescription on discharge to hospice care JP Furuno, BN Noble, KN Horne, JC McGregor, MR Elman, DT Bearden, ... Antimicrobial agents and chemotherapy 58 (9), 5473-5477, 2014 | 50 | 2014 |
Penetration of macrolides into pulmonary sites of infection DT Bearden, KA Rodvold Infections in Medicine 16, 480-485, 1999 | 50 | 1999 |
Clinical pharmacokinetics of quinupristin/dalfopristin DT Bearden Clinical pharmacokinetics 43, 239-252, 2004 | 48 | 2004 |
Statewide impact of pharmacist-delivered adult influenza vaccinations DT Bearden, T Holt American journal of preventive medicine 29 (5), 450-452, 2005 | 45 | 2005 |
Evaluation of antifungals in the surgical intensive care unit: a multi‐institutional study KW Garey, MM Neuhauser, DT Bearden, JP Cannon, RE Lewis, ... Mycoses 49 (3), 226-231, 2006 | 38 | 2006 |
Efficacy of oral β-lactam versus non-β-lactam treatment of uncomplicated cellulitis KJ Madaras-Kelly, RE Remington, CM Oliphant, KL Sloan, DT Bearden The American journal of medicine 121 (5), 419-425, 2008 | 36 | 2008 |
Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus DT Bearden, GP Allen, JM Christensen Journal of Antimicrobial Chemotherapy 62 (4), 769-772, 2008 | 35 | 2008 |